S. Trachsel

Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study

G. Gaudernack, T. Buanes, S. Bernhardt, 2006, British Journal of Cancer.

Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination

G. Gaudernack, J. Kyte, P. Straten, 2009, Cancer Immunology, Immunotherapy.

Immunocytochemical detection of isolated epithelial cells in bone marrow: non‐specific staining and contribution by plasma cells directly reactive to alkaline phosphatase

J. Nesland, B. Naume, E. Schlichting, 1998, The Journal of pathology.

Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer

S. Aamdal, G. Kvalheim, G. Gaudernack, 2006, Cancer Immunology, Immunotherapy.

Vaccination of patients with cutaneous melanoma with telomerase-specific peptides

G. Gaudernack, L. Braathen, R. Hunger, 2011, Cancer Immunology, Immunotherapy.

Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study

G. Gaudernack, T. Buanes, S. Bernhardt, 2006, British Journal of Cancer.

A phase I/II study of telomerase peptide vaccination in combination with chemotherapy in patients with stage IV malignant melanoma.

S. Aamdal, O. Engebraaten, G. Gaudernack, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001

G. Gaudernack, S. Trachsel, K. Lislerud, 2012, Oncoimmunology.

Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients

S. Aamdal, G. Gaudernack, S. Dueland, 2011, Clinical Cancer Research.

Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood.

B. Naume, S. Funderud, K. Beiske, 1997, Journal of hematotherapy.

T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth

G. Kvalheim, G. Gaudernack, S. Wälchli, 2017, Oncoimmunology.